3/24/2024

Polymyxin B and Trimethoprim Sulfates Ophthalmic Solution

Products Affected - Description

- Polymyxin B and Trimethoprim Sulfates ophthalmic solution, Akorn, 10,000 unit/mL - 1 mg/mL, 10 mL bottle, NDC 17478-0703-11 - discontinued
- Polymyxin B and Trimethoprim Sulfates ophthalmic solution, Greenstone (Viatris), 10,000 unit/mL - 1 mg/mL, 10 mL bottle, NDC 60758-0908-10 - discontinued
- Polymyxin B and Trimethoprim Sulfates ophthalmic solution, Sandoz, 10,000 unit/mL - 1 mg/mL, 10 mL bottle, NDC 61314-0628-10

Reason for the Shortage

- Akorn ceased operations in February 2023.
- Bausch Health polymixin B and trimethoprim sulfates ophthalmic solution available.
- Greenstone (Viatris) discontinued polymyxin B and trimethoprim sulfates ophthalmic solution in 2022.
- Sandoz did not provide a reason for the shortage.

Available Products

- Polymyxin B and Trimethoprim Sulfates ophthalmic solution, Bausch Health, 10,000 unit/mL - 1 mg/mL, 10 mL bottle, NDC 24208-0315-10

Estimated Resupply Dates

- Sandoz has polymixin B and trimethoprim sulfates ophthalmic solution on back order and the company estimates a release date of late-March 2024.

Updated

Updated March 24, 2024 by Elyse MacDonald, PharmD, MS, BCPS. Created March 31, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.